1 Yet, the same 1,829 persons disclosed that only 1% of them were ever told about dependence and withdrawals after antidepressant use
While that study highlighted a handful of variants associated with modest differences in outcomes, this work identifies combinatorial biomarker signatures that stratify patients and quantitatively predict responseand is already being translated into tests designed for use in real treatment decisions, a company representative told Inside Precision Medicine
This approach aligns with improving the overall quality of life for women who wish to conceive post-treatment, assuming successful cancer remission
That means brands may need to lean into health benefits, functional ingredients, or a little extra novelty to catch attention
Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS, et al
Reappraisal of GIP pharmacology for metabolic diseases